OR WAIT null SECS
April 15, 2022
GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9 billion.
April 11, 2022
Ymmunobio AG has signed a patent purchase agreement with LeukoCom GmbH to expand its development of cancer therapies.
Pfizer plans to acquire ReViral and its respiratory syncytial virus therapeutic candidates to strengthen Pfizer’s capabilities in infectious disease research.
April 08, 2022
Evonetix’s thermally controlled DNA synthesis technology is designed to enable highly parallel DNA synthesis in a benchtop platform.
April 06, 2022
Standardization is needed in CAR-T cell therapy development due to its inherent complexity.
April 02, 2022
Advances in pharmaceutical neuroscience present an opportunity for pharmaceutical companies to stay ahead of the curve.
March 31, 2022
Consumer advocates continue to press for initiatives to lower drug prices by revising or reducing patent protections.
March 24, 2022
Teva has reached an agreement with the Attorney General of Rhode Island to settle opioid-related claims.
March 18, 2022
Emmes has acquired Casimir, marking its fourth major acquisition.
March 15, 2022
The US Congress approved a federal spending package that increases funding for a range of programs to advance health and medicine.